Home » Accordion » ZOLEDRONATE

Zoledronate

For those with Paget's disease who require treatment, the current first-line bisphosphonate, due to its potency and prolonged duration of action, is zoledronate (zoledronic acid). It is the bisphosphonate most likely to relieve pain from active Paget’s disease. A single infusion of 5mg is given and over the following months, often normalises the abnormal bone remodelling. This single dose can be effective for many years. 

• 5 mg of Zoledronic acid intravenously over 15-30 minutes 

• One dose may be effective for many years

Paget's Clinical Guideline

You can download a PDF of the full Guideline here: *Diagnosis and Management of Paget’s Disease of Bone in Adults - A Clinical Guideline 2019 Alternatively, download a summary of the Guideline - Paget's Guideline Summary 2019

 

Page to appear on: 

Receive the paget’s magazine

By becoming a member

Become a Friend of the Paget's Association

If you are not a member of the Association, but would like to stay up to date with our news and events via our mailing list, please sign up here to become a Friend of the Association. Please note, if you are a member, there's no need to sign up here as you already receive our updates and much more!

Your Details